Delivery Order SPE2DB24D1205-SPE2DB25FCTAT

Award Date 1/14/25
Potential Completion Date 1/15/25
Potential Value $31K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $61,765.98, is for the supply of BIMZELX 160 MG/ML AUTOINJECTORML, a specialty pharmaceutical product. The contract has a firm-fixed price pricing type and an ultimate completion date of July 3, 2024. The contract is not designated with any set-aside requirements, indicating open...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,108.93, is for the delivery of BIMZELX 160 MG/ML AUTOINJECTORML, a specialty medication. The contract has a completion date of July 29, 2024 and is a Firm Fixed Price contract. There is no set-aside designation indicated for this award. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $11,791.12, is for the supply of BIMZELX 160 MG/ML AUTOINJECTOR ML, a specialty medication. The contract has a firm fixed-price pricing structure and an ultimate completion date of October 11, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) between...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,632.69 Firm Fixed Price Delivery Order is for the supply of BIMZELX 160 MG/ML AUTOINJECTORML, a medical product. The contract has an ultimate completion date of March 7, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, with the ID SPE2DX15D3005|SPE2DX24F3SPG, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,187.00, is a Firm Fixed Price Delivery Order for the supply of BIMZELX 160 MG/ML AUTOINJECTORML, a medical product. The contract has a period of performance through July 5, 2024. Amerisourcebergen Drug Corp is the prime contractor...
This federal contract award, identified as SPE2DB22D3009|SPE2DB25FAR34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,052.04, is for the delivery of the drug BIMZELX 160 MG/ML AUTOINJECTORML. This is a Firm Fixed Price Delivery Order contract with a completion date of February 14, 2025. The contract does not have a set-aside designation, indicating open...
This federal contract award, with an ID of SPE2DB20D2104|SPE2DB25FMGVG, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,802.33 firm-fixed-price delivery order covers the supply of BIMZELX 160 MG/ML AUTOINJECTORML, a medical product, to support federal healthcare programs. The contract is not designated as a set-aside and serves as a delivery order under AmerisourceBergen's existing...
This federal contract award, with an ID of SPE2DB25D3005|SPE2DB25FQBKA, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of BIMZELX 160 MG/ML AUTOINJECTORML, which is a medical product. The contract has a ceiling value of $23,419.36 and is a firm fixed-price delivery order that runs until January 3, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,373.24 and a period of performance through March 7, 2025. It is a firm fixed-price contract for the procurement of various pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes,...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $37,140.48 and an ultimate completion date of February 4, 2025. It is a Firm Fixed Price contract for the delivery of a range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes,...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCTAT
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BIMZELX 160 MG/ML AUTOINJECTORML, a pharmaceutical product, with a ceiling value of $30,685.35 and a period of performance through January 15, 2025. The contract is a firm-fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 4/16/25, 5:59 PM